| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1038/NRNEPH.2017.63 |
| P698 | PubMed publication ID | 28555652 |
| P50 | author | Ron T Gansevoort | Q98733545 |
| Marcello Tonelli | Q28360280 | ||
| Judith Gout-Zwart | Q59684581 | ||
| Wim Van Biesen | Q62576244 | ||
| Lieven Annemans | Q55076306 | ||
| Raymond Vanholder | Q55232541 | ||
| Norbert Lameire | Q55233075 | ||
| Rachael Morton | Q43140522 | ||
| P2093 | author name string | Rainer Oberbauer | |
| Maarten J Postma | |||
| Carmine Zoccali | |||
| Edwina Brown | |||
| European Kidney Health Alliance | |||
| P2860 | cites work | Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease | Q95418518 |
| Lifetime medical costs of obesity: prevention no cure for increasing health expenditure | Q21144656 | ||
| Association between smoking and chronic kidney disease: a case control study | Q21257300 | ||
| The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors | Q21563399 | ||
| Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians | Q22305315 | ||
| Food label use and awareness of nutritional information and recommendations among persons with chronic disease | Q23915123 | ||
| Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease | Q24235834 | ||
| Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada | Q24645546 | ||
| Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice | Q26767011 | ||
| Dialysis or conservative care for frail older patients: ethics of shared decision-making | Q26851298 | ||
| Does AKI truly lead to CKD? | Q27024744 | ||
| A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. | Q27860879 | ||
| Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis | Q27968225 | ||
| The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes | Q28188182 | ||
| Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis | Q28195576 | ||
| Use and understanding of nutrition information on food labels in six European countries | Q56913018 | ||
| Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of r | Q57316368 | ||
| Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries | Q57535574 | ||
| Cost-Effectiveness of Initiating Dialysis Early: A Randomized Controlled Trial | Q59167561 | ||
| Health expenditure growth: reassessing the threat of ageing | Q60721814 | ||
| Australian consumer perspectives on dialysis: First national census | Q61523963 | ||
| Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population | Q61965156 | ||
| Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2) | Q62522613 | ||
| Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance | Q78570334 | ||
| Home care assistance and the utilization of peritoneal dialysis | Q79693183 | ||
| The prevention challenge and opportunity | Q79884871 | ||
| Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in | Q80384676 | ||
| The deadly risk of late referral | Q80425720 | ||
| The organization and financing of kidney dialysis and transplant care in the United States of America | Q80548776 | ||
| Peritoneal dialysis in Ontario: a natural experiment in physician reimbursement methodology | Q81046681 | ||
| Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement | Q81448726 | ||
| The food industry and self-regulation: standards to promote success and to avoid public health failures | Q82282062 | ||
| Early dialysis of no benefit to the patient or the health care system | Q83877218 | ||
| The initiation of renal-replacement therapy--just-in-time delivery | Q84484585 | ||
| Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement | Q84885786 | ||
| Pre-dialysis hospital use and late referrals in incident dialysis patients in England: a retrospective cohort study | Q85303629 | ||
| BMA calls for 20% sugar tax to subsidise cost of fruit and vegetables | Q85582677 | ||
| Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease | Q95418507 | ||
| The possible impact of the US prospective payment system ("bundle") on the growth of peritoneal dialysis | Q28661124 | ||
| Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy | Q28740641 | ||
| The Role of Acute Kidney Injury in Chronic Kidney Disease | Q30248695 | ||
| Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies | Q30250220 | ||
| Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data | Q30961976 | ||
| United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease | Q30975799 | ||
| The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry | Q30993094 | ||
| "The high cost of dying": what do the data show? 1984. | Q31017011 | ||
| Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data. | Q31033237 | ||
| Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands | Q33634922 | ||
| Population based study of social and productive activities as predictors of survival among elderly Americans | Q33644825 | ||
| Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe | Q33719803 | ||
| Dietary salt reduction in hypertension--what is the evidence and why is it still controversial? | Q33743183 | ||
| Recent advances: nephrology | Q33811023 | ||
| Investing in youth tobacco control: a review of smoking prevention and control strategies | Q33848364 | ||
| Need for differential discounting of costs and health effects in cost effectiveness analyses | Q33920490 | ||
| Patients' perceptions of information and education for renal replacement therapy: an independent survey by the European Kidney Patients' Federation on information and support on renal replacement therapy | Q33982530 | ||
| Consequences of late referral on patient outcomes | Q34060386 | ||
| Functional status of elderly adults before and after initiation of dialysis | Q37462390 | ||
| Obesity and overweight in Canada: an updated cost-of-illness study | Q37469260 | ||
| Limited health literacy is associated with low glomerular filtration in the Chronic Renal Insufficiency Cohort (CRIC) study | Q37632818 | ||
| Dialysis in late life: benefit or burden | Q37645617 | ||
| The economic considerations of patients and caregivers in choice of dialysis modality | Q37663914 | ||
| Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease | Q37693993 | ||
| Dietary Sodium and Cardiovascular Disease Risk--Measurement Matters | Q37738736 | ||
| Chronic kidney disease associated with environmental toxins and exposures | Q37741497 | ||
| Nutrition labels on pre-packaged foods: a systematic review | Q37829483 | ||
| Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes | Q37924974 | ||
| The developmental origins of health | Q37965468 | ||
| Increasing the pool of deceased donor organs for kidney transplantation | Q37997296 | ||
| Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline | Q38003117 | ||
| Acute kidney injury: an increasing global concern | Q38111137 | ||
| Nephrology in Africa--not yet uhuru | Q38130063 | ||
| Health economics and European Renal Best Practice--is it time to bring health economics into evidence-based guideline production in Europe? | Q38134696 | ||
| Acute kidney injury-epidemiology, outcomes and economics | Q38180360 | ||
| Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure | Q38214140 | ||
| Acute kidney injury and chronic kidney disease as interconnected syndromes | Q38225657 | ||
| Economic evaluation of dialysis therapies | Q38243366 | ||
| Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease | Q38249494 | ||
| Dietary and fluid restrictions in CKD: a thematic synthesis of patient views from qualitative studies | Q38277873 | ||
| Clinical management of the uraemic syndrome in chronic kidney disease | Q38382365 | ||
| Ageing of population and health care expenditure: a red herring? | Q38498867 | ||
| Cost of renal replacement: how to help as many as possible while keeping expenses reasonable? | Q38537462 | ||
| Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients | Q38588084 | ||
| Improving outcomes of acute kidney injury survivors | Q38625897 | ||
| Does pre-emptive transplantation versus post start of dialysis transplantation with a kidney from a living donor improve outcomes after transplantation? A systematic literature review and position statement by the Descartes Working Group and ERBP. | Q38633089 | ||
| Assisted Peritoneal Dialysis for Older People with End-Stage Renal Disease: The French and Danish Experience | Q38678649 | ||
| Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease. | Q38832593 | ||
| The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease | Q38913638 | ||
| Preferences for Policy Options for Deceased Organ Donation for Transplantation: A Discrete Choice Experiment | Q38954454 | ||
| Decisions about Renal Replacement Therapy in Patients with Advanced Kidney Disease in the US Department of Veterans Affairs, 2000-2011. | Q38962336 | ||
| Trends in consumption of ultra-processed foods and obesity in Sweden between 1960 and 2010. | Q39025804 | ||
| Screening for proteinuria in US adults: a cost-effectiveness analysis. | Q50735258 | ||
| Smoking as a risk factor for end-stage renal failure in men with primary renal disease. | Q50866934 | ||
| Relationship between Health Literacy and Kidney Function. | Q50962028 | ||
| A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. | Q51141068 | ||
| Cost-effectiveness analysis of renal replacement therapy in Austria. | Q51158730 | ||
| The economic impact of acute kidney injury in England. | Q51244962 | ||
| A randomized, controlled trial of early versus late initiation of dialysis. | Q51685434 | ||
| Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. | Q51906731 | ||
| International study of health care organization and financing: development of renal replacement therapy in Germany. | Q53230877 | ||
| A study of the quality of life and cost-utility of renal transplantation. | Q53621261 | ||
| Screening: Screening for kidney disease--a lost opportunity. | Q54502722 | ||
| On the Concept of Health Capital and the Demand for Health | Q56020808 | ||
| The impact of presumed consent legislation on cadaveric organ donation: A cross-country study | Q56638886 | ||
| Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. | Q34141636 | ||
| When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study | Q34183375 | ||
| An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems: a panel study | Q34246467 | ||
| Mediterranean diet and cardiodiabesity: a review | Q34263468 | ||
| Population based screening for chronic kidney disease: cost effectiveness study | Q34286311 | ||
| Chronic kidney disease: global dimension and perspectives | Q34347984 | ||
| Cost of peritoneal dialysis and haemodialysis across the world | Q34348767 | ||
| Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) | Q34375901 | ||
| Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians | Q34379261 | ||
| CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy | Q34397105 | ||
| Corner Store Inventories, Purchases, and Strategies for Intervention: A Review of the Literature | Q34443603 | ||
| The Declaration of Istanbul on Organ Trafficking and Transplant Tourism | Q34595502 | ||
| Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence | Q34617694 | ||
| The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial | Q34630074 | ||
| Current issues in measurement and reporting of urinary albumin excretion | Q34657704 | ||
| Measured GFR as a confirmatory test for estimated GFR. | Q34659317 | ||
| Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis | Q34660044 | ||
| School food policy at Dutch primary schools: room for improvement? Cross-sectional findings from the INPACT study | Q34669058 | ||
| An analysis of the economic impact of smoking cessation in Europe | Q34687287 | ||
| The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes | Q34718385 | ||
| Modelling of usual nutrient intakes: potential impact of the choices programme on nutrient intakes in young dutch adults | Q34981474 | ||
| Cost-effectiveness of primary screening for CKD: a systematic review. | Q35094743 | ||
| Hospital-acquired acute kidney injury: an analysis of nadir-to-peak serum creatinine increments stratified by baseline estimated GFR. | Q35096865 | ||
| Expanded criteria donors for kidney transplantation. | Q35106631 | ||
| How much will Herceptin really cost? | Q35167009 | ||
| Added value of screening for CKD among the elderly or persons with low socioeconomic status | Q35278606 | ||
| Cost and health consequences of reducing the population intake of salt | Q35402965 | ||
| Development of international criteria for a front of package food labelling system: the International Choices Programme | Q35529117 | ||
| Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting | Q35629882 | ||
| Risk Prediction for Early CKD in Type 2 Diabetes | Q35691583 | ||
| Sodium intake, ACE inhibition, and progression to ESRD. | Q35720736 | ||
| Economics of smoking cessation | Q35747001 | ||
| Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD. | Q35790521 | ||
| Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. | Q35839493 | ||
| Maternal Smoking during Pregnancy, Household Smoking after the Child's Birth, and Childhood Proteinuria at Age 3 Years | Q39070582 | ||
| Differential time preferences for money and quality of life | Q39264001 | ||
| The effect of longevity on spending for acute and long-term care | Q39536657 | ||
| Reimbursement of dialysis: a comparison of seven countries | Q39606264 | ||
| Population ageing in the United States of America: implications for public programmes | Q39611564 | ||
| Consent for research with biological samples: one-time general consent versus a gift model | Q39628467 | ||
| Projected reduction in healthcare costs in Belgium after optimization of iodine intake: impact on costs related to thyroid nodular disease | Q39819022 | ||
| The effects of the Danish saturated fat tax on food and nutrient intake and modelled health outcomes: an econometric and comparative risk assessment evaluation. | Q39856463 | ||
| The potential health and economic effect of a Body Mass Index decrease in the overweight and obese population in Belgium | Q39963637 | ||
| Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study. | Q40452726 | ||
| Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population | Q40515850 | ||
| Levels of physical activity among adults 18-64 years old in 28 European countries | Q40615424 | ||
| Slowing the progression of chronic renal failure: economic benefits and patients' perspectives | Q40650099 | ||
| Epidemiology: Global Burden of Disease Study 2013 reports that disability caused by CKD is increasing worldwide | Q40810460 | ||
| Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study. | Q40938685 | ||
| Cost to government and society of chronic kidney disease stage 1-5: a national cohort study. | Q40972894 | ||
| Burden of Sickness Absence Due to Chronic Disease in the Dutch Workforce from 2007 to 2011. | Q41169229 | ||
| Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study | Q41596673 | ||
| Effective CKD care in European countries: challenges and opportunities for health policy | Q41749000 | ||
| Dietary Sodium and Cardiovascular Disease Risk | Q42366527 | ||
| Assisted Peritoneal Dialysis as an Alternative to In-Center Hemodialysis | Q42397851 | ||
| The management of older adults with a low eGFR: moving toward an individualized approach | Q42575496 | ||
| Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease | Q42937685 | ||
| Global trends in the rates of living kidney donation | Q43410169 | ||
| Renal replacement therapy: how can we contain the costs? | Q43831219 | ||
| Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation | Q43871012 | ||
| Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators | Q43959042 | ||
| Dialysis: Choice of dialysis--what to do with economic incentives | Q44311418 | ||
| Universal coverage of renal dialysis in Thailand: promise, progress, and prospects | Q44418434 | ||
| Significance of frailty among dialysis patients | Q44505719 | ||
| Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. | Q44561011 | ||
| A population-based study of the incidence and outcomes of diagnosed chronic kidney disease | Q44603637 | ||
| A closer look at the economic argument for disease prevention | Q44944861 | ||
| Association between smoking and chronic renal failure in a nationwide population-based case-control study | Q45000531 | ||
| Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe | Q45001774 | ||
| Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria | Q45113233 | ||
| Economic burden of obesity and its comorbidities in Switzerland | Q45130004 | ||
| Chronic kidney disease and life expectancy | Q45171544 | ||
| Increasing consumption of ultra-processed foods and likely impact on human health: evidence from Brazil. | Q45735658 | ||
| Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. | Q45926202 | ||
| Reinvesting in health post-2015. | Q46072416 | ||
| Processed foods: contributions to nutrition. | Q46627206 | ||
| Global sodium consumption and death from cardiovascular causes | Q46673378 | ||
| Potential impact of population-based colorectal cancer screening in Canada. | Q47253763 | ||
| Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus | Q47774395 | ||
| To treat or not to treat? Cost-effectiveness of ace inhibitors in non-diabetic advanced renal disease - a Dutch perspective | Q48240111 | ||
| Use of food nutrition labels is associated with lower fat intake. | Q50538503 | ||
| A step toward solving the long-term care dilemma for living kidney donors. | Q50552184 | ||
| Health, life expectancy, and health care spending among the elderly. | Q50725296 | ||
| Association of age and BMI with kidney function and mortality: a cohort study | Q35991609 | ||
| The Population Health Model (POHEM): an overview of rationale, methods and applications | Q36025063 | ||
| Consumer understanding and use of nutrition labelling: a systematic review | Q36037621 | ||
| Living donor practices in the United States | Q36062331 | ||
| Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment | Q36067446 | ||
| Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis | Q36068812 | ||
| Chronic kidney disease as cause of cardiovascular morbidity and mortality | Q36091038 | ||
| Nutrition Labeling to Prevent Obesity: Reviewing the Evidence from Europe | Q36133643 | ||
| Preventing chronic diseases: how many lives can we save? | Q36300585 | ||
| Estimating the financial cost of chronic kidney disease to the NHS in England | Q36358702 | ||
| Association between sodium intakes with the risk of chronic kidney disease: evidence from a meta-analysis | Q36492918 | ||
| Priorities among effective clinical preventive services: methods | Q36507914 | ||
| Early dialysis initiation and rates and timing of withdrawal from dialysis in Canada | Q36583326 | ||
| Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis | Q36671628 | ||
| Cost-effectiveness of enzyme replacement therapy for Fabry disease | Q36688268 | ||
| Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP). | Q36711180 | ||
| Development of the Croatian model of organ donation and transplantation | Q36722749 | ||
| Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events | Q36729160 | ||
| Urinary Sodium and Potassium Excretion and CKD Progression | Q36746060 | ||
| A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction | Q36770933 | ||
| Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease | Q36885527 | ||
| The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care | Q36887224 | ||
| Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison | Q36928201 | ||
| Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. | Q36951197 | ||
| Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use | Q37026089 | ||
| The Effectiveness of Health Literacy Oriented Programs on Physical Activity Behaviour in Middle Aged and Older Adults with Type 2 Diabetes: A Systematic Review | Q37049592 | ||
| Preventing fatal diseases increases healthcare costs: cause elimination life table approach | Q37149934 | ||
| Do healthier foods and diet patterns cost more than less healthy options? A systematic review and meta-analysis | Q37374403 | ||
| Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? | Q37378412 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P577 | publication date | 2017-05-30 | |
| P1433 | published in | Nature Reviews Nephrology | Q2079275 |
| P1476 | title | Reducing the costs of chronic kidney disease while delivering quality health care: a call to action |
| Q90622171 | Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data |
| Q90461852 | An International Analysis of Dialysis Services Reimbursement |
| Q90018538 | Association Between Dialysis Facility Ownership and Access to Kidney Transplantation |
| Q90345487 | Association of TGF-β1, IL-4, and IL-10 Polymorphisms With Chronic Kidney Disease Susceptibility: A Meta-Analysis |
| Q57701181 | Chronic kidney disease |
| Q90325628 | Chronic kidney disease: considerations for monitoring skeletal muscle health and prescribing resistance exercise |
| Q89869484 | Cost-effectiveness of Deceased-donor Renal Transplant Versus Dialysis to Treat End-stage Renal Disease: A Systematic Review |
| Q55476982 | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). |
| Q99545742 | Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data |
| Q64105482 | Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? |
| Q90151563 | Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey |
| Q90392805 | Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design |
| Q96686077 | Ethical challenges in nephrology: a call for action |
| Q49060040 | Further approaches to reduce the cost of renal replacement therapy |
| Q46775402 | Gradual initiation of dialysis as a means to reduce cost while providing quality health care. |
| Q92638441 | Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data |
| Q60303562 | Improving safety and efficiency in care: multi-stakeholders' perceptions associated with a peritoneal dialysis virtual care solution |
| Q91740512 | Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care |
| Q90182797 | Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care |
| Q98178877 | Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care |
| Q90672119 | Kidney Health for Everyone Everywhere: From Prevention to Detection and Equitable Access to Care |
| Q102379535 | Kidney health in the context of economic development |
| Q58561315 | Lipid management in patients with chronic kidney disease |
| Q90371913 | Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma |
| Q94048808 | Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe |
| Q90182808 | Preventing CKD in Developed Countries |
| Q102059168 | Sustainable Development Goals relevant to kidney health: an update on progress |
| Q41660722 | The ABCC6 Transporter: A New Player in Biomineralization. |
| Q98177250 | The current and future landscape of dialysis |
| Q90426312 | The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment |
| Q64109604 | Uptake and Scalability of a Peritoneal Dialysis Virtual Care Solution: Qualitative Study |
| Q47781932 | Urinary peptidomics in kidney disease and drug research |
Search more.